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Perceptions of US Adolescents and Adults With Sickle Cell Disease
on Their Quality of Care
Julie Kanter, MD; Robert Gibson, PhD; Raymona H. Lawrence, DrPH, MPH; Matthew P. Smeltzer, PhD; Norma L. Pugh, MS; Jeffrey Glassberg, MD; Rita V. Masese, MD;
Allison A. King, MD, MPH; Cecelia Calhoun, MD; Jane S. Hankins, MD, MS; Marsha Treadwell, PhD

Abstract
IMPORTANCE Sickle cell disease (SCD) is the most common inherited red blood cell disorder in the
United States, and previous studies have shown that individuals with SCD are affected by multiple
health disparities, including stigmatization, inequities in funding, and worse health outcomes, which
may preclude their ability to access quality health care. This needs assessment was performed as

Key Points
Question What are the barriers to care
experienced by adolescents and adults
living with sickle cell disease in the
United States?

part of the Sickle Cell Disease Implementation Consortium (SCDIC) to assess barriers to care that may

Findings This survey study conducted

be faced by individuals with SCD.

by the Sickle Cell Disease
Implementation Consortium enrolled

OBJECTIVE To assess the SCD-related medical care experience of adolescents and adults with SCD.

440 adolescents and adults in 7
different states and found that most

DESIGN, SETTING, AND PARTICIPANTS This one-time survey study evaluated pain interference,

respondents were pleased with their

quality of health care, and self-efficacy of 440 adults and adolescents (aged 15 to 50 years) with SCD

usual care physicians but had negative

of all genotypes and assessed how these variables were associated with their perceptions of

experiences in acute care settings. Pain

outpatient and emergency department (ED) care. The surveys were administered once during office

and the frequency of pain episodes were

visits by trained study coordinators at 7 of 8 SCDIC sites in 2018.

associated with patient-reported selfefficacy, further emphasizing the

RESULTS The SCDIC sites did not report the number of individuals approached to participate in this

association of severe pain with poor

study; thus, a response rate could not be calculated. In addition, respondents were not required to

outcomes in this population.

answer every question in the survey; thus, the response rate per question differed for each variable.
Of 440 individuals with SCD, participants were primarily female (245 [55.7%]) and African American
(428 [97.3%]) individuals, with a mean (SD) age of 27.8 (8.6) years. The majority of participants (306
of 435 [70.3%]) had hemoglobin SS or hemoglobin S β0-thalassemia. Most respondents (361 of 437
[82.6%]) reported access to nonacute (usual) SCD care, and the majority of respondents (382 of 413

Meaning A negative perception of care
in the emergency department setting
may be a barrier for seeking care among
adolescents and adults living with sickle
cell disease.

[92.1%]) noted satisfaction with their usual care physician. Of 435 participants, 287 (66.0%)
reported requiring an ED visit for acute pain in the previous year. Respondents were less pleased with
their ED care than their usual care clinician, with approximately half (146 of 287 [50.9%]) being
satisfied with or perceiving having adequate quality care in the ED. Participants also noted that when
they experienced severe pain or clinician lack of empathy, this was associated with a negative quality
of care. Age group was associated with ED satisfaction, with younger patients (<19 vs 19-30 and

+ Invited Commentary
+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

31-50 years) reporting better ED experiences.
CONCLUSIONS AND RELEVANCE These results suggested that a negative perception of care may
be a barrier for patients seeking care. These findings underscore the necessity of implementation
studies to improve access to quality care for this population, especially in the acute care setting.
JAMA Network Open. 2020;3(5):e206016. doi:10.1001/jamanetworkopen.2020.6016
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Introduction
Improving access to health care and providing broad implementation of guideline-based health care
services for individuals with sickle cell disease (SCD) are the ultimate goals of the Sickle Cell Disease
Implementation Consortium (SCDIC), funded by the National Heart, Lung, and Blood Institute. The
SCDIC aims to conduct multicenter studies using implementation science to accelerate the
translation of science discoveries into clinical practice.1 One of the first consortium activities was to
develop a patient-centered needs assessment to explore patient experiences with the quality and
availability of health care and the associated patient-level factors. This information will be used to
inform and guide the projects developed and implemented by the consortium. This article describes
the results of this needs assessment and its relevance to future consortium activities.
Sickle cell disease is an inherited hemoglobinopathy and multisystem disease with acute
complications, mainly painful vasoocclusive events, chronic progressive organ damage (eg,
nephropathy and cardiomyopathy), and reduced life expectancy.2 In the United States, SCD affects
approximately 100 000 individuals.3 Most are African American or Hispanic individuals and many are
subject to disparities associated with geographic access to services and to low socioeconomic status.
Despite wide-ranging literature that explores barriers to care—including clinician- and systemdriven barriers in SCD (eg, lack of qualified SCD clinicians,4 presence of disease, and racial/ethnic
bias)5,6—patient-level experiences (eg, pain interference and self-efficacy) and patient perceptions
of care quality have largely been overlooked. To our knowledge, the present survey study is the first
comprehensive multiregional assessment of patient-level experiences.
Access to health care services is defined as the timely use of personal health services to achieve
the best health outcomes.7 Three steps are critical in ensuring optimal access to health services in
the United States: ingress into the health care system (eg, having adequate health care coverage),
access to a location where needed health care services are provided, and identification of a clinician
who the patient trusts and maintains communication with.8 The lack of available health care services
(including knowledgeable clinicians) may lead to greater morbidity and even early mortality. Access
to health care services is reported as suboptimal in SCD because many affected individuals are not
receiving adequate treatment as outlined by evidence-based clinical guidelines.9-11 Adults with SCD
often may not be seen by an SCD specialist, do not receive appropriate analgesia during
vasoocclusive pain episodes, and are underprescribed disease-modifying therapies, such as
hydroxyurea or long-term transfusion.12,13 Lack of access to health care services adds to the
vulnerability of the SCD population, imparting greater risk of severe disease complications and
early death.
Quality of health care can be measured or reported in a variety of ways. Indicators of quality in
health care are traditionally used to assess measures of care delivery provided by clinicians.
Historically (in SCD), these may include vaccination delivery14 or prescribing of antibiotics or diseasemodifying agents.15 These indicators are often evaluated to identify target areas for improvement.
From an individual’s perspective, patient satisfaction can also be used to measure the quality of care
delivered. Although it is not clear that patient satisfaction equates to health outcomes, research
suggests that patient evaluation of care is important to enhance patient engagement, to identify
opportunities to improve health plans, and for benchmarking.16 Patient satisfaction is a complex
paradigm that juxtaposes individuals’ health care experiences against their expectation of care.
Differences in treatment expectations between patients and clinicians may contribute to
patient-level satisfaction.17 It is also important to note that it is often the interpersonal skills of the
clinician—courtesy, empathy, and respect in addition to communication skills—that have been shown
to be as essential as other technical skills, such as clinical competency and hospital equipment. The
ultimate goal of the present study was to identify the individual-level impediments associated with
obtaining health care services to inform the design of intervention strategies within implementation
projects to be developed.
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Methods
SCDIC Needs Assessment Process
The SCDIC is a cooperative research program comprising 8 academic or clinical sites and 1 data
coordinating center distributed in locations across the US with high populations of individuals with
SCD.1 The SCDIC activities are divided into 2 phases: a needs assessment (phase 1) and
implementation studies (phase 2) with continuous registry enrollment. The needs assessment was
initiated in the first year of the project to inform the design, development, and deployment of
implementation studies. The needs assessment was designed as a concurrent mixed-methods18
approach including cross-sectional surveys, focus groups, and interviews with individuals with SCD
and with clinicians. The present study assessed only the development and results of a survey of
individuals with SCD. Our deployment of the needs assessment survey was aligned with best
practices for survey research,19 including focusing on specific goals, generating a representative
sample, matching questions to domains of interest, pilot testing the survey and procedures, training
study coordinators in the conduct of the survey, and providing quality assurance. When designing
the survey, we allowed respondents to skip questions that they were not comfortable answering
(and continue the survey). Thus, response rates may differ by question (eTable in the Supplement).
Institutional review board approval, including protection of participants’ confidentiality, was
obtained by all sites. Once a person with SCD agreed to participate in this study, trained coordinators
obtained informed consent from adults, and if the individual was a minor, from the legal guardian.
Assent was obtained from adolescents between the ages of 15.0 and 17.9 years. Written informed
consent or assent was obtained by research staff members of the respective SCDIC sites during
routine clinic visits in accordance with the institutional guidelines based on the Declaration of
Helsinki.20 Participants were compensated with gift cards for their involvement.

Participant Selection
Individuals with SCD were eligible for this survey if they (1) had received a confirmed diagnosis of SCD
(any genotype), (2) lived in the geographic region of 1 of the 8 sites that participated in this activity,
(3) were between 15 and 50 years of age, and (4) were not experiencing acute symptoms of SCD.
Unlike other SCDIC studies, this study permitted the inclusion of individuals up to 50 years of age to
obtain more information regarding the needs of patients in this age group. The age limitations were
specified by the request for application for this grant project. Although this was predominantly a
convenience sample, efforts were made to achieve a broad reach from a heterogeneous group of the
affected population. Participants were recruited through clinicians, websites, posted flyers,
recruitment letters, health fairs, and clinical programs. Most participants were identified and
recruited during clinical visits. Data collection occurred in the community or when participants were
in an outpatient setting from July 2017 through March 2018. Table 1 gives characteristics of
participating SCDIC sites, strategies for recruitment, and ultimate enrollment.

Survey Domains Development
The needs assessment survey was designed to capture individual-level data using a combination of
previously validated surveys collected using a standard approach across the SCDIC centers.21
Representatives from the 8 SCDIC clinical centers, the data coordinating center (RTI International),
and the National Heart, Lung, and Blood Institute met regularly to develop measurement strategies
for the needs assessment. Potential domains of interest were generated by the committee, and the
final list of domains was determined through a consensus process.
The following criteria were applied to select the measures. Measures had to (1) be validated for
use with patients with SCD, (2) address the domains of interest, and (3) allow for standardized
administration in all participating sites. Once the final set of measures was assembled, patient
consultants at 2 sites (North Carolina and California) beta tested the measures and provided the
investigators with input about the relevance, understandability, and the amount of time required to
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complete the set of measures. The survey was then finalized and field tested with approximately 10
patients at each site without further changes and then broadly used in all participating sites (the full
survey is available on request).
This needs assessment survey used patient-reported measures in 4 major domains: (1) pain
interference and experience (health-related quality of life), (2) quality of health care, (3) social
determinants of health, including numerous demographics, and (4) self-efficacy regarding SCD.
These 4 domains were selected to evaluate specific areas of care, experiences, and coping that could
be targeted by interventions in different geographic locations and for different age groups.

Survey Procedures
Participants completed the survey in a private space immediately after providing informed consent
or were scheduled for a separate visit at a convenient time and location. Participants with known or
observed reading difficulties completed the survey as an interview. Participants could complete the
survey on a tablet, with responses recorded directly in a Research Electronic Data Capture
(REDCap)22 database. Alternatively, participants could complete a paper version, and results were
then transferred to the REDCap database. Participants typically completed the survey in 15 to
20 minutes.

Survey Measures
Demographic and Clinical Characteristics
Participants self-reported age, gender, race, ethnicity, and SCD phenotype using items from the
consensus measures for Phenotypes and eXposures (PhenX) Toolkit, version 13.1, SCD Core
demographic and clinical measures.23,24 Survey participants indicated the frequency of SCD pain
episodes that they had experienced in the previous year, including the extent of any interference
with usual daily activities but in the absence of health care use.
Pain Interference
Participants completed the Patient Reported Outcomes Measurement Information System (PROMIS)
4-item Pain Interference Short Form.25 PROMIS is an initiative funded by the National Institutes of

Table 1. Characteristics of Participating SCDIC Sites

Estimated
total No. of
adults with
SCD (≥18 y)

Estimated
total No. of
children with
SCD (<18 y)

Inpatient
Outpatient
services on site services on site

ED on
site

Infusion
center or
ability to
provide
acute care
in clinic

St Jude
Children’s
Research
Hospital

400

850

Yes

Yes

Yes

Yes

Urban

Clinic

Tablet

101

Washington
University

350

400

Yes

Yes

Yes

Yes

Urban

Community

Paper

19

Duke University

450

450

Yes

Yes

Yes

Yes

Urban

Clinic

Tablet

50

Augusta
University

796

897

Yes

Yes

Yes

No

Rural and
urban

Clinic

Tablet

163

Site

Survey site
setting

Survey
equipment

No. of
participants
enrolled

Mount Sinai

734a

80b

Yes

Yes

Yes

Yesc

Urban

Clinic, inpatient Tablet, paper

29

UCSF

708

276d

Yes

Yes

Yes

Yes

Urban

Clinic,
community

Tablet, paper

55

MUSC

600

500

Yes

Yes

Yes

Yes

Rural and
urban

Clinic

Tablet

86

Abbreviations: ED, emergency department; MUSC, Medical University of South Carolina;
SCD, sickle cell disease; SCDIC, Sickle Cell Disease Implementation Consortium; UCSF,
University of California, San Francisco.
a

Primarily
urban or rural
practice

Total number of unique adults older than 15 years seen across the Mount Sinai Health
System, which includes 6 hospitals. Total at Mount Sinai Hospital = 381 (250 followed
up in a clinic, 131 who were not followed up in a clinic but intermittently used acute
care services).

b

Only children below 15 years of age.

c

Limited infusion capabilities for adults based on availability at the cancer center.

d

For a 5-county region, not just the clinic at UCSF. Within the region, patients had access
to adult and pediatric inpatient, ED, and infusion units, but institutions varied
throughout the region.
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Health to develop and validate patient-reported outcomes for clinical research and practice. Its
measures have been developed and validated with state-of-the-science methods to be
psychometrically sound and to transform how life domains are measured.26 The PROMIS Pain
Interference measure has shown clinical relevance for adults with SCD.7
Participants in the present study indicated how much pain interfered with daily activities in the
previous 7 days, including with work around the home, social activities, and household chores. Items
were scored on a 5-point Likert scale, with 1 indicating “not at all” to 5 indicating “very much,” and
total scores were generated by the HealthMeasures Scoring Service,27 a software application that
automates and facilitates item response theory–calculated scoring of short-form data from
HealthMeasures measurement systems, including PROMIS. Scores generated by the software
included a T score with a mean (SD) of 50 (10). We used this T score for our analysis, with higher
scores indicating more pain interference.
Quality of Care
We used a fixed-format questionnaire, the Adult Sickle Cell Quality of Life Measurement Information
System (ASCQ-Me) quality of care (QoC) measure,10 to assess the health care experience of
participants. Themes from the ASCQ-Me QoC formative research informed the construction of the
ASCQ-Me QoC survey questions that were also modeled after the Consumer Assessments of
Healthcare Providers and Systems (CAHPS) surveys.28-35
The ASCQ-Me QoC survey consisted of 27 questions, but skip patterns allowed respondents to
complete the survey in as few as 5 questions if they did not have any SCD-related pain in the previous
12 months and had never sought emergency or ambulatory care. Thirteen ASCQ-Me QoC questions
loaded on 3 domains of health care quality. The first domain, provider communication, consisted of 4
items mirroring the CAHPS provider communication domain; for example, “In the past 12 months,
how often did the doctor or nurse listen carefully to you?” (rated never to always). The second
domain, emergency department (ED) care, included 5 items regarding the patient’s interaction with
staff (doctors, nurses, clerks, or receptionists) during emergency visits, including items that go
beyond the CAHPS ED care domain by asking about the extent to which clinicians believed that the
patient had severe pain and how successfully pain was treated in the ED. The third domain, access,
consisted of 3 items, for example, “In the past 12 months, when you tried to make an appointment to
see a clinician, how often were you able to get one as soon as you wanted?” (rated never to always).
Although the CAHPS access to care only reflects access to outpatient care, the ASCQ-Me access
composite included questions about access to both ED and outpatient care and a question about the
influence of bad experiences on decisions to seek care.
Three questions addressed global evaluations of care by asking participants how often they
were satisfied (never to always) with their usual clinician and with the QoC received from their usual
clinician and from the ED. Participants also provided an overall evaluation of all the care they received
on a scale from 0 to 10, anchored from worst to best care possible. Separate scores are produced for
each of the 4 global questions. For the preceding 12 months, participants reported on the number of
visits with their usual clinician, the number of ED visits for pain, and episodes of pain managed at
home without going to a doctor, clinic, or hospital. Three other questions measure participants’
perceptions of how knowledgeable their primary care clinician was about SCD. The ASCQ-Me QoC
composite scores have shown reliability (Cronbach α = 0.70-0.83), and QoC has been shown to be
reliable, with good construct validity (r = 0.32-0.83 correlations with global care ratings) and good
precision for discriminating among groups experiencing poor QoC. In the ASCQ-Me QoC testing
phase, adults with SCD reported worse care compared with adult Medicaid populations
completing CAHPS.10
SCD Self-efficacy
The Sickle Cell Self-Efficacy Scale (SCSES)36 was used to assess self-efficacy for participants’
perceived ability to deal with daily aspects of SCD, such as pain and fatigue. The SCSES consisted of

JAMA Network Open. 2020;3(5):e206016. doi:10.1001/jamanetworkopen.2020.6016 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 08/29/2020

May 29, 2020

5/18

JAMA Network Open | Hematology

Patient Perceptions of Quality of Care for Sickle Cell Disease

9 items, with responses ranging from 1 (not at all sure) to 5 (very sure) on a Likert scale. Responses
were summed so that higher scores indicated a higher degree of self-efficacy. The reliability and
validity of the SCSES has been documented, with Cronbach α of 0.89 and significant positive
correlations between SCSES scores and standardized measures of self-esteem, mastery, and locus of
control.36 The SCSES has shown predictive validity, with higher self-efficacy correlated with fewer
physician and ED visits.36 For adolescents with SCD, high levels of self-efficacy have been associated
with fewer physical and psychological symptoms.37 In a systematic review of published papers
between 2003 and 2013, studies that tested the association between self-efficacy and SCD
outcomes showed positive correlations between self-efficacy during transition from pediatric to
adult care and positive patient outcomes in the SCD population.38

Data Collection and Storage
A REDCap database was housed at each SCDIC institution, with uniform data structure across sites
for all elements.22 Deidentified participant-level data were shared from each site to the data
coordinating center for centralized data analyses.

Statistical Analysis
Summary statistics were calculated for all survey results, including frequency and percentage for
categorical variables and mean, standard deviation, median, and interquartile range (IQR) for
continuous variables. Age was evaluated as a continuous and as a categorical variable (<19, 19-30, and
31-50 years). Some individual measures had a smaller sample than the total number, in which case
percentages are reported based on these smaller samples. We used univariate and multivariable
models (linear regression for continuous outcomes and logistic regression for binary outcomes) to
evaluate associations between demographic and disease characteristics and quality of care outcome
variables. Multivariable models controlled for age group, gender, and SCD genotype as confounders
and evaluated age group as an effect modifier with interaction terms. In addition to summary
statistics, linear regression results included P values for overall associations. Logistic regression
results included model-based odds ratio estimates with 95% CIs and P values for overall associations.
The P values are reported at the .05 level with no adjustments for multiple comparisons.39 All
analyses were conducted in SAS, version 9.4 (SAS Institute Inc).

Results
Participant Demographic and Clinical Characteristics
A total of 440 participants completed the survey and provided adequate responses for analysis. Sites
did not report the number of individuals approached to participate in this study; thus, a response
rate could not be calculated. Furthermore, respondents were not required to answer every question
in the survey; thus, the response rate per question also differed for each variable. Sample sizes for
each variable are reported in the eTable in the Supplement. Of 440 respondents, most were female
(245 [55.7%]) and African American (428 [97.3%]) or non-Hispanic (418 [95.0%]) individuals, with a
mean (SD) age of 27.8 (8.6) years (Table 2). A total of 128 of 371 respondents (34.5%) of the heads
of household reported some college or an associate; degree. In addition, 131 of 433 respondents
(30.3%) reported that they received disability income, but 50.8% were working (116 [26.8%]) or
were students (104 [24.0%]). Few (84 of 433 [19.4%]) were married or living with a partner, and 268
of 404 respondents (66.3%) reported annual household incomes of less than $30 000. Of 424
respondents with health insurance, approximately one-third had more than 1 type of insurance. In
total, 263 of 386 respondents (68.1%) reported receiving Medicaid (including some who had
Medicaid in combination with Medicare or private insurance). Of 391 respondents, 137 (35.0%)
reported receiving Medicare, and some of these participants also had other insurance types. The
primary SCD diagnoses received by the respondents were hemoglobin (Hb) variant SS or Hb S
β0-thalassemia (306 of 435; 70.3%).
JAMA Network Open. 2020;3(5):e206016. doi:10.1001/jamanetworkopen.2020.6016 (Reprinted)
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Table 2. Patient Demographic and Clinical Characteristics
Characteristic

No. (%) of respondents

Total No.

440

Age, y
≥18

92 (20.9)

19-30

176 (40.0)

31-50

172 (39.1)

Age, continuous, y
Mean (SD)

27.8 (8.6)

Median (interquartile range)

28 (20-34)

Gender
Male

193 (43.9)

Female

245 (55.7)

No response

2 (0.4)

Race
African American

428 (97.3)

Other

8 (1.8)

No response

3 (0.7)

Ethnicity
Hispanic, Latino, or Spanish

13 (3.0)

Not Hispanic, Latino, or Spanish

418 (95.0)

No response

9 (2.1)

Highest degree received, head of household
≤12th Grade, no diploma

40 (10.8)

High school graduate or GED

93 (25.1)

Some college, AA degree

128 (34.5)

Bachelor’s degree or above

87 (23.4)

No response

23 (6.2)

Current employment status
Working now

116 (26.8)

Other

80 (18.5)

Disabled

131 (30.3)

Student

104 (24.0)

No response

2 (0.5)

Marital status
Married or living together

84 (19.4)

Other

340 (78.5)

No response

9 (2.1)

Annual income, $
<9999

151 (37.4)

10 000-29 999

117 (29.0)

≥30 000

108 (26.7)

No response

28 (6.9)

Genotype
Hb SS, Hb S β0-thalassemia

306 (70.3)

Hb SC disease

88 (20.2)

+

Hb S β -thalassemia

18 (4.1)

Other variant

2 (0.5)

Don’t know

21 (4.8)
(continued)
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Table 2. Patient Demographic and Clinical Characteristics (continued)
Characteristic

No. (%) of respondents

Health insurance
Private health insurance

70 (16.5)

Medicare

129 (30.4)

Medicaid

166 (39.2)

Other

21 (5.0)

No coverage of any type

9 (2.1)

Don’t know

29 (6.8)

Abbreviations: AA, associate of arts; GED, General Educational Development;
Hb S, hemoglobin variant S; Hb SC, hemoglobin variant SC.

Pain Interference
Many participants experienced SCD-related pain. In the previous year, 287 of 437 participants
(65.7%) reported requiring the ED for acute episodes of pain. In the previous 6 months, 168 of 437
participants (38.4%) reported 3 or more treat-and-release ED visits for pain, but 327 of 433
participants (75.6%) reported severe pain episodes at home for which they did not seek health care.
In the previous 6 months, 210 of 327 participants (64.2%) reported at least 4 such pain episodes,
and 207 of 323 participants (64.1%) also reported that they missed at least 1 week from usual
activities because of pain at home. Although 147 of 436 participants (33.7%) reported no hospital
admissions for pain in the previous 12 months, 151 of 436 participants (34.6%) reported 3 or more
hospital admissions for pain during the same time frame.
The mean (SD) pain interference T score for participants in the present study was 59.2 (9.9)
(median score, 61.3; IQR, 54.6-66.7; range, 41.6-75.6) suggesting a higher proportion of patients
experiencing pain interference compared with the general population completing PROMIS pain
measures.39 The mean (SD) SCSES score for participants in the present study was 30.8 (7.7) (median
score, 31.0; IQR, 26.0-36.0; range, 9.0-45.0), similar to reference samples.36
Pain interference scores were associated with several important demographic factors (Table 3).
Female participants (mean [SD]: females, 60.6 [9.6]; males, 57.3 [10.2]; P ⱕ .001), participants who
were married or living together (mean [SD]: married or living together, 61.8 [8.6]; others, 58.7 [10.1];
P = .01), and those receiving disability income (mean [SD]: disabled, 64.0 [7.3]; working, 57.6 [10.3];
student, 55.4 [11.1]; and others, 58.1 [9.0]; P < .001) all reported significantly higher levels of pain
interference. Annual income was inversely associated with pain interference score (mean [SD]:
earning <$9999, 60.9 [9.4]; earning $10 000-$29 999, 58.8 [10.3]; earning ⱖ$30 000, 57.8 [10.0];
P = .04). Participants with Medicare or Medicaid or with no insurance also reported higher pain
interference scores. Reported numbers of pain episodes (mean [SD]: 0 episodes, 50.7 [9.8]; <4
episodes, 58.1 [9.4]; ⱖ4 episodes, 64.1 [6.9]), severe pain (mean [SD]: yes, 61.9 [8.4]; no, 50.7 [9.8]),
ED use (mean [SD]: 0 visits, 53.7 [10.4]; 1-2 visits, 59.6 [9.2]; ⱖ3 visits, 63.8 [7.3]), hospitalization for
pain (mean [SD]: 0 admissions, 53.9 [10.1]; 1-2 admissions, 59.6 [9.3]; ⱖ3 admissions, 63.9 [7.7]), and
days of usual activity missed (mean [SD]: <1 week, 57.7 [8.6]; ⱖ1 week, 64.3 [7.3]) were all associated
with pain interference scores (P < .001). When adjusted for age group, gender, and SCD genotype,
findings associated with pain interference remained statistically significant for health care and painrelated covariates (Table 3).

Quality of Care
The ASCQ-Me QoC was used to obtain data on usual (outpatient, nonacute) care and ED care. For the
current sample, the ASCQ-Me QoC items loaded on 2 factors (provider communication and ED care)
excluding an item asking about access to outpatient appointments (goodness-of-fit measures: root
mean square error of approximation, 0.07; Bentler comparative fit index, 0.94). We reported
composite scores (items that loaded onto the factors) and individual scores for both usual care and
ED care.
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Table 3. SCD Self-efficacy and Pain Interference

Covariate (No. missing from subgroup total)

SCD self-efficacy (n = 413)

Pain interference (n = 437)

Mean (SD)

Mean (SD)

P value

P value

Gender (2)
Male

31.4 (8.1)

Female

30.4 (7.3)

Age, y (0)

30.8 (7.7)

57.3 (10.2)
.21
<.001

60.6 (9.6)
59.2 (9.9)

<.001
<.001

Race (4)
African American

30.9 (7.7)

Other

27.0 (6.0)

59.0 (9.9)
.22

67.9 (4.3)

.02

Ethnicity (12)
Hispanic

29.9 (7.5)

Not Hispanic

30.8 (7.7)

63.5 (10.4)
.70

59.0 (9.9)

.13

Head of HH educational level (58)
<HS

29.8 (9.2)

HS or GED or some college

30.2 (7.6)

59.3 (10.3)

College graduate or professional

31.9 (7.5)

58.4 (10.1)

Working now

32.9 (7.4)

57.6 (10.3)

Disabled

28.1 (7.1)

Student

32.1 (7.6)

Other

30.9 (7.4)

.12

59.7 (10.0)

.50

Employment (9)

64.0 (7.3)
<.001

55.4 (11.1)

<.001

58.1 (9.0)

Marital status (14)
Married or living together

30.8 (7.4)

Other

30.9 (7.6)

61.8 (8.6)
.89

58.7 (10.1)

.01

Annual income $ (55)
<9999

28.8 (7.4)

10 000-29 999

31.5 (7.6)

60.9 (9.4)

≥30 000

32.5 (7.2)

57.8 (10.0)

Private

32.6 (6.8)

57.2 (10.7)

Medicare or Medicaid

30.3 (7.6)

Other insurance

33.1 (7.4)

No coverage

28.7 (8.1)

60.1 (11.6)

SS or S β0

31.0 (7.7)

59.3 (10.2)

SC

30.9 (7.5)

S β+

30.6 (7.6)

Other variant (n = 2)a

40.0 (0.0)

55.5 (4.1)

0

33.6 (7.8)

53.7 (10.4)

1-2

30.6 (6.9)

≥3

28.4 (7.3)

<.001

58.8 (10.3)

.04

Medical insurance (38)

60.2 (9.7)
.06

.03

55.2 (10.1)

Phenotype (23)

59.1 (9.7)
.42

57.5 (8.9)

. 83

No. of treated-and-released ED visits, 6 mo (0)a

<.001

59.6 (9.2)

<.001

63.8 (7.3)

Severe pain, no health care, 6 mo (4)a
Yes

29.8 (7.4)

No

33.8 (7.7)

<.001

61.9 (8.4)

<.001

50.7 (9.8)

No. of pain episodes, 6 mo (104)a
<4

32.7 (6.9)

≥4

28.2 (7.2)

58.1 (9.4)
<.001

64.1 (6.9)

<.001

No. of pain episodes, 6 mo (4)a
0

33.8 (7.7)

<4

32.7 (6.9)

≥4

28.2 (7.2)

50.7 (9.8)
<.001

58.1 (9.4)

<.001

64.1 (6.9)
(continued)
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Table 3. SCD Self-efficacy and Pain Interference (continued)

Covariate (No. missing from subgroup total)

SCD self-efficacy (n = 413)

Pain interference (n = 437)

Mean (SD)

Mean (SD)

P value

P value

No. of days missed usual activities, 6 mo (107)a
<1 wk

32.9 (7.2)

≥1 wk

28.2 (7.0)

57.7 (8.6)
<.001

64.3 (7.3)

<.001

No. of hospital admissions for pain, 12 mo (1)a
0

33.5 (8.0)

1-2

31.1 (6.8)

≥3

27.9 (7.0)

53.9 (10.1)

Abbreviations: ED, emergency department; GED,
General Educational Development; HH, household;
HS, high school; SCD, sickle cell disease.
a

<.001

59.6 (9.3)

<.001

63.9 (7.7)

Covariate remained significant (for SCD self-efficacy
and for pain interference) when adjusted for age
group, gender, and phenotype.

Usual Care (Defined as Outpatient Clinic Visit, Nonacute)
Of 437 respondents, 361 (82.6%) reported that they had a usual clinician for nonacute care. Of 361
respondents in this group, 300 (80.3%) reported their usual clinician typically treated “a lot of
patients with SCD.” On the provider communication composite (Table 4),40 76% reported that the
provider explained things in a way they could understand, listened to them, and treated them with
courtesy and respect. The 1 area in which the clinicians were not scored as highly was the ability to
spend enough time with patients (66% rated their experiences as the most positive). The majority
(314 of 341) of respondents (92.1%) noted they were “usually or always” satisfied with their usual
clinicians, and 268 of 325 respondents (82.5%) were “usually or always” satisfied with care received
during scheduled appointments. More than half (185 of 341; 54.3%) reported their usual clinician
“very much” knew how SCD affected them personally.
Questions about access to care were also posed to participants. Screening questions showed
that 326 of 435 survey participants (74.9%) had attempted to make an appointment with a physician
or nurse in the previous 12 months. In the composite analysis, when participants accessed outpatient
health care, 76% were satisfied or somewhat satisfied with the time it took to get the physician or
nurse appointment.
In logistic regression models, pain experience had a substantial negative association with
satisfaction with scheduled nonacute appointments. Patients were less likely to be satisfied when
they experienced severe pain (OR, 0.318 [95% CI, 0.093-0.823]; P = .03) or had 4 or more pain
episodes (vs 0) in 6 months (OR, 0.237 [95% CI, 0.069-0.622]; P = .001) (Table 5).

ED Care
Information about the location of the EDs used by participants was not collected. In total, 66% of
respondents reported having had an ED visit in the previous 12 months. On the ED composite
(Table 4), 29% reported having the most negative experience possible, 39% reported neutral
experiences, and only 32% reported having the most positive experience possible. Overall, only half
(146 of 287 [50.9%]) were “usually or always” satisfied with ED care received, and 52% indicated
that bad experiences in the ED influenced their decisions to avoid seeking care. Only 26% of
respondents were always satisfied with their ED care. Of 379 participants, 254 (67.0%) reported that
they had delayed or avoided going to the ED when they thought they needed care in the previous 12
months. The ED composite analysis indicated that 47% of respondents gave the most negative
ratings when asked if physicians seemed to “really care” about them; 35% gave the most negative
ratings regarding whether nurses seemed to “really care” about them; 61% were neutral with regard
to whether ED clinicians helped with their pain; and 50% were neutral when asked if clinicians
believed how bad their pain was.
In logistic regression models, employment status was significantly associated with ED care
satisfaction (Table 5). Compared with respondents who were currently working, participants who did
not work and received disability income were 66% less likely to be satisfied with ED care. Students
and those with “other” employment status (temporarily laid off, sick leave or maternity leave; looking
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for work, unemployed; retired; keeping house) also reported less satisfaction, although this finding
was not statistically significant.

ASCQ-Me QoC Compared With CAHPS
Table 4 gives the distribution of responses for the ASCQ-Me access to care composite compared with
the 2017 CAHPS Clinician & Group Survey (N = 25 789) and the ASCQ-Me QoC field test sample
(N = 561). Participants in the needs assessment rated their overall access to care as similar to
participants in the ASCQ-Me field test. Both groups rated their overall access to care as the worst
possible 41% of the time, whereas for the adult Medicaid sample, only 18% gave the worst possible
rating. More than half of the adult Medicaid sample gave their overall access the best possible rating
compared with approximately 30% of both the SCDIC and ASCQ-Me field test samples. Ratings of
access to care to the ED contributed greatly to these ratings of overall access. The majority of both
the SCDIC needs assessment and ASCQ-Me field test samples rated their access to ED care as the
worst possible, whereas the majority of the adult Medicaid sample rated their access to ED care as
the best possible. In addition, 45% were satisfied with the time it took to receive ED care, and 35% of
patients experienced ED wait times of more than 2 hours.

Table 4. Quality of Care Composites
Composite score, %a
Composite

Never or sometimes

Usually

Always

SCDIC needs assessment

41

28

31

ASCQ-Me field test

41

30

28

CAHPS adult Medicaid 2017

18

27

55

SCDIC needs assessment

8

16

76

ASCQ-Me field test

12

23

65

CAHPS adult Medicaid 2017

9

17

74

SCDIC needs assessment

55

26

19

ASCQ-Me field test

49

30

21

CAHPS adult Medicaid 2017

16

21

63

Access to care compositeb

Clinician communication compositec

Access to emergency department cared

Abbreviations: ASCQ-Me, Adult Sickle Cell Quality of Life Measurement Information System; CAHPS, Consumer
Assessments of Healthcare Providers and Systems; SCDIC, Sickle Cell Disease Implementation Consortium.
a

As stated in the ASCQ-Me User’s Manual “The interpretation of the composites is less straightforward than with the
individual items, since the composite score is derived by combining responses from multiple individual items.”40(p7) With
that caveat, percentages for the composites (and 1 individual item) are summarized here. For consistency with the
scoring guide, categories were labeled “never or sometimes, usually, and always,” where “always” defined respondents
who reported the most positive response. Note, however, that not all items were scored on this scale.

b

For SCDIC and the ASCQ-Me field test populations, this composite was composed of the following items: “In the past 12
months, …when you tried to make an appointment to see DR/RN, how often were you able to get one as soon as you
wanted; …when you needed care right away, how often did you get it as soon as you wanted; …what is the longest you
had to wait before your pain was treated; and how important were bad experiences in the emergency room in your
decision to avoid going for care.” For the CAHPS adult Medicaid 2017 population, this composite was composed of the
following items: “How often was easy to get needed care, tests, or treatment”; and “got appointments with specialists as
soon as needed.”

c

For SCDIC and the ASCQ-Me field test populations, this composite was composed of the following items: “In the past 12
months, …how often did this doctor or nurse explain things in a way that is easy to understand; …how often did this
doctor or nurse listen carefully to you; …how often did this doctor or nurse treat you with courtesy and respect; and
…how often did this doctor or nurse spend enough time with you.” For the CAHPS adult Medicaid 2017 population, this
composite was composed of the following items: “Personal MD …explained things clearly; …listened carefully;
…respected consumer comments; and …spent enough time with consumers.”

d

For SCDIC and the ASCQ-Me field test populations, this individual item was worded as “In the past 12 months, when you
needed care right away, how often did you get it as soon as you wanted.” For the CAHPS adult Medicaid 2017 population,
this item was worded as “Got urgent care for illness, injury, or condition as soon as needed.”
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Table 5. Patient Perceived Quality of Care

Covariate (No. missing of 413)
Gender (1)
Male

Satisfaction with regularly
schedule appointment

Satisfaction with emergency
department use

Odds ratio (95% CI)
0.932 (0.518-1.657)

Odds ratio (95% CI)
0.699 (0.435-1.121)

1 [Reference]

Age, y (0)

P value
.81

1.006 (0.971-1.042)

1-Unit increase

1 [Reference]

Race (4)

1 [Reference]

Ethnicity (11)

1 [Reference]

1 [Reference]

.35

1.286 (0.279-6.627)
.43

2.49 (0.513-9.766)

Hispanic

.14

0.987 (0.959-1.015)
.75

0.508 (0.106-3.608)

African American

1 [Reference]

P value

1 [Reference]

.74

2.729 (0.578-19.288)
.21

1 [Reference]

.24

Head of HH educational level (41)
College graduate or professional

1 [Reference]

HS or GED

0.735 (0.363-1.460)

1 [Reference]

<HS

0.584 (0.214-1.771)

1.288 (0.495-3.388)

Working now

1 [Reference]

1 [Reference]

Disabled

0.919 (0.425-1.947)

Other

0.785 (0.328-1.911)

.52

1.463 (0.856-2.513)

.38

Employment (6)

Student
Marital status (7)
Married or living together

0.34 (0.180-0.630
.92

0.556 (0.259-1.182)

1.074 (0.447-2.661)

0.81 (0.396-1.656)

1.032 (0.492-2.035)

0.999 (0.552-1.806)

1 [Reference]

.93

1 [Reference]

.004

>.99

Annual income, $ (37)
≤9999

0.781 (0.349-1.692)

10 000-29 999

0.565 (0.250-1.236)

0.784 (0.414-1.478)

≥30 000

1 [Reference]

1 [Reference]

Private

1 [Reference]

1 [Reference]

Medicare or Medicaid

0.575 (0.209-1.343)

Other insurance

1.955 (0.300-38.487)

No coverage

0.326 (0.055-2.618)

0.619 (0.101-3.784)

SS or S β0

1 [Reference]

1 [Reference]

SC

0.61 (0.313-1.233)

S β+

2.073 (0.388-38.384)

Other

Undefineda

.36

0.894 (0.455-1.749)

.74

Medical insurance (23)
0.564 (0.263-1.172)
.36

2.063 (0.516-10.483)

.13

Phenotype (19)
0.827 (0.450-1.513)
.44

0.926 (0.251-3.420)

.83

No. of treat-and-release ED visits, 6 mo (0)
0

1 [Reference]

1-2

0.633 (0.252-1.512)

≥3

0.441 (0.189-0.939)

Severe pain, no health care, 6 mo (2)a
No
No. of pain episodes, 6 mo (57)
<4

.12

0.465 (0.222-0.931)
.03

0.306 (0.128-0.650)
1 [Reference]

0.431 (0.184-0.963)
0.466 (0.206-1.001)

0.318 (0.093-0.823)
1 [Reference]

a

1 [Reference]
.11

1 [Reference]

.03

0.535 (0.304-0.934)
.004

1 [Reference]

.03
Abbreviations: ED, emergency department; GED,
General Educational Development; HH, household;
HS, high school.

No. of pain episodes, 6 mo (2)b
None

1 [Reference]

<4

0.775 (0.198-2.593)

≥4

0.237 (0.069-0.622)

No. of days missed of usual activities,
6 mo (60)c
<1 wk
No. of hospital admissions for pain,
12 mo (1)c
0

1 [Reference]
.001

0.724 (0.314-1.623)

0.557 (0.266-1.097)
1 [Reference]

≥3

0.708 (0.315-1.508)

Covariate remained significant (for appointment
satisfaction only) when adjusted for age group,
gender, and phenotype.

.002

b

Covariate remained significant (for both
appointment satisfaction and emergency
department satisfaction) when adjusted for age
group, gender, and phenotype.

c

Covariate remained significant (for emergency
department satisfaction) when adjusted for age
group, gender, and phenotype.

1 [Reference]

1 [Reference]
0.517 (0.228-1.110)

a

0.394 (0.215-0.706)
.10

1-2

.01

0.388 (0.182-0.792)

1 [Reference]
.25

0.385 (0.158-0.870)

.01

0.267 (0.111-0.593)
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Sickle Cell Disease Self-efficacy
The associations with demographic and clinical characteristics on self-efficacy were evaluated with
linear regression models (Table 3). There were no significant differences in SCD self-efficacy by
gender, race, ethnicity, marital status, or disease phenotype. Older age, disabled employment status,
and lower annual income were associated with significantly lower SCD self-efficacy scores.
Significantly lower self-efficacy was also associated with more frequent pain episodes and frequency
of severe pain episodes for which the individual did not seek treatment. Higher ED utilization rates
and hospitalization rates for pain were also associated with lower SCD self-efficacy. Finally,
participants with lower self-efficacy were more likely to miss usual activities because of disease
complications. When adjusted for age group, gender, and SCD genotype, findings associated with
self-efficacy remained statistically significant for health care and pain-related covariates.

Age-Specific Results
We evaluated the association of each age group (<19, 19-30, 31-50 years) with the variables. Because
the study included patients 15 to 18 years of age who were more likely to be treated in pediatric
facilities and adults older than 18 years of age who were more likely to be treated in adult-focused
facilities, it was necessary to evaluate these differences. There was no significant difference in the
associations with satisfaction and usual appointments by age group. However, there was a notable
difference in ED satisfaction by age group. Specifically, respondents who were younger than 19 years
were more likely to be satisfied with ED care compared with those who were 31 to 50 years. We also
found that the associations between ED satisfaction and degree of pain at home and between ED
satisfaction and interference of pain with activities were modified by age group. Specifically, the
association between severe pain at home without seeking health care and ED satisfaction differed
significantly by age. Respondents who experienced severe pain without seeking health care and were
younger than 19 years were more likely to be satisfied with ED care, whereas respondents who
experienced severe pain without seeking health care and were aged 19 to 30 years were less likely to
be satisfied with ED care. Respondents who managed severe pain at home and who missed doing
their usual activities for at least 1 week were less likely to be satisfied with ED care. This finding did
not differ across age groups.

Site-Specific Results
There were no significant differences in appointment satisfaction, ED satisfaction, self-efficacy, or
pain interference across the 7 sites participating in this study. Thus, results are consistent across sites
and should be considered comprehensively.

Discussion
This survey study represents the first multiregional needs assessment evaluation for SCD. The
participants included individuals with SCD from different states, with different backgrounds, and
across settings of care. However, when considering these results, it is important to acknowledge that
these observations came from patients treated at some of the most prominent SCD treatment
centers in the US. Although these patients’ individualized observations are made in the context of the
relative availability of SCD specialty outpatient care, they can be used to highlight the importance of
access to care. The results of these findings are being used in the development of the upcoming
implementation trials for SCD. The novel findings of the present study include the significance of
patient satisfaction with their usual clinicians despite concerns about their ED care.
It is also important to note the significant association of pain with self-efficacy. Many individuals
within this participant group reported frequent pain episodes. Individuals with SCD were clearly
concerned with their pain and the treatment of their pain. Our study is consistent with previous work
that shows that many individuals experience high pain interference because of their SCD. Pain
interference was also associated with the way individuals feel about the treatment they had received.
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However, although the frequency and severity of pain were associated with greater perceived care
quality in the nonacute setting, this perception was not associated with self-efficacy or
sociodemographic factors.
This is the first study, to our knowledge, to identify that a majority of adolescents and adults
with SCD (82.6%) had access to nonacute, usual SCD care. However, these “usual care” clinicians
were not always colocated in the same hospital where individuals received their acute care. In
addition, ED physicians may not have had the opportunity to communicate with primary SCD
physicians when individuals presented for acute painful events. A lack of communication and
comanagement may have influenced respondents’ appraisal of ED care. We observed slightly fewer
than half of respondents (49%) being satisfied with or perceived having adequate quality care within
the ED setting. The experience in the ED of having severe pain or of feeling there was a lack of
empathy for expressed pain was associated with a negative perceived quality of care. This negative
perception of care in the ED is not unique to patients with SCD but shared with other patient
populations with certain chronic conditions (ie, chronic obstructive pulmonary disease, congestive
heart failure, asthma, and diabetes with diabetic ketoacidosis) who frequently visit the ED.41-46
Noticeably, patient satisfaction with ED care was higher in younger patients (<19 years) who were
likely treated in pediatric facilities. Although unsurprising, it is certainly relevant to consider the
differences in treatment of the same disease in different age-specific settings.
Overall, the ED findings are not new but are of interest when contrasted with the patient
satisfaction in the nonacute environment. Furthermore, these results suggested the need to improve
communication and comanagement to prevent these perceived negative experiences of care in the
acute setting. These findings are therefore important when designing an implementation study to
enhance care for affected individuals. A focus on both ensuring that individuals have access to an
SCD specialist (usual clinician) and improving comanagement in the ED has therefore been a target of
the implementation project.
Self-efficacy has not been well studied in previous SCD assessments. We found that self-efficacy
was not associated with gender, race, ethnicity, or marital status. However, older individuals and
those with disabled employment status (and lower annual income) had significantly lower SCD selfefficacy scores. This is especially important in recognizing the association of social determinants with
health for this patient population. Self-efficacy was also notably associated with pain and with the
frequency of pain episodes, further emphasizing the association of severe pain with poor outcomes
in SCD. This finding is also important for showing why attention to pain management may facilitate
both patient engagement and enhanced care engagement. Furthermore, this degree of pain
interference and its association with self-efficacy is, to our knowledge, a novel finding. The finding is
important for the development of strategies in which additional care management plans may be
necessary for individuals who have lower self-efficacy to improve patient engagement.
Results from this needs assessment have been incorporated into the focus and design of the
SCDIC implementation projects. One project is focused on individualizing the care experience in the
ED to address concerns with consistent, meaningful, and rapid treatment of pain. Given the level of
satisfaction with typical outpatient SCD care in this patient population, this study recognizes the
importance of ensuring access to care for all affected individuals. Thus, another implementation
project is exploring how best to identify and engage individuals who are not receiving adequate SCD
care (unaffiliated patients). The third project is specifically examining strategies that can harness the
positive patient-clinician relationship to increase hydroxyurea uptake and treatment adherence.

Limitations
This study has several limitations. The primary limitation was the inability to generalize many of these
findings to all individuals in this age group living with SCD in the United States. The majority of the
participants in the present study had an identified clinician who was also an SCD specialist, which is
not true for many individuals living with SCD. The survey components were chosen to specifically
understand individual experiences with pain and with access to care to inform development of
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implementation strategies to overcome these barriers. In configuring the original survey, a minimum
set of survey instruments was included as well as a menu of instruments that could be selected from
to create an “enhanced” survey. Most sites selected the minimum survey to minimize participant
burden, but then domains such as barriers to care and health literacy could not be assessed for the
entire needs assessment sample. Furthermore, not every potential factor influencing outcomes
could be assessed in one needs assessment (eg, health beliefs). Finally, this survey specifically
assessed individual-level responses and did not include clinician- or system-level barriers to care.
Those topics are addressed in separate forthcoming articles. In addition, more in-depth qualitative
interviews were also performed with a subset of participants, which will also add additional valuable
information to future articles.

Conclusions
In conclusion, this study had several notable findings. It was clear that pain remained a barrier to selfefficacy for individuals with SCD in addition to affecting their quality of life. Many patients reported
excellent communication and satisfaction with their usual clinician. However, care in the ED appeared
to be lacking because of perceived lack of empathy from clinicians who provided acute care and may
have limited disease-specific knowledge. Thus, many individuals with SCD may avoid seeking acute
care because of noted concerns and poor responsiveness to their concerns, which may lead to poor
outcomes. Attention is being paid to these issues in the upcoming SCDIC ED-focused implementation
trial. Of paramount importance, however, is the level of satisfaction reported by patients who had
an SCD physician. Unfortunately, many patients are without this benefit. As found in the present
study, comfort with a usual clinician can enhance individuals’ perception of their quality of care and
may provide the necessary relationship from which to improve outcomes. Thus, it is important that
we use the SCDIC projects to identify and help individuals with SCD locate and engage with a
knowledgeable clinician. It is equally important that strategies be implemented to enhance
communication between the usual clinician and ED providers to improve trust, decrease stigma, and
increase satisfaction with pain management.
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